When available, the Online Course format is included with the hard copy, eBook, or audio book formats!
Start Date: September 16, 2016
Expiration Date: September 16, 2019
Anticoagulants are central to the management of cardiovascular and thrombotic conditions. Parenteral anticoagulants are particularly important in acute care situations given their fast onset of action. They are indicated for the management of acute coronary syndromes (ACS), in the treatment and prevention of venous thromboembolism (VTE), and in the management of heparin-induced thrombocytopenia (HIT). With the variety of oral anticoagulants now available, it is also important that pharmacists recognize the changing role of parenteral anticoagulants when the indications overlap with those of oral therapy. Furthermore, they must be able to safely transition patients from parenteral to oral anticoagulants.
This course is designed for pharmacists who are involved in decision making for parenteral anticoagulant selection or who provide care for patients who have already been prescribed a parenteral anticoagulant. The purpose of this course is to increase pharmacists’ knowledge of parenteral anticoagulants so that they can identify patients in whom therapy is indicated, assist in selecting the most appropriate option, and monitor and counsel the patient.
The focus of this course is on parenteral anticoagulants, their most pertinent prescribing information, and strategies for effective patient monitoring and counseling. This course begins with an overview of current practice guidelines for VTE prevention and treatment, HIT, and ACS. Then, an overview of the prescribing information for each associated parenteral anticoagulant follows, including strategies for reversal, patient monitoring, and counseling when applicable.
Universal Activity Number (UAN) - 0607-0000-16-008-H01-P
Type of Activity - Knowledge
Topic Designator - 01 – Disease State Management/Drug Therapy
- Identify the current role of parenteral anticoagulants in the management of patients with venous thromboembolism (VTE) and for VTE prophylaxis, acute coronary syndromes (ACS), and heparininduced thrombocytopenia (HIT).
- Compare and contrast parenteral anticoagulants, their respective pharmacologic class, and their approved indications.
- Identify pertinent contraindications, side effects, drug interactions, monitoring parameters, and patient counseling points for parenteral anticoagulants.
- Identify reversal agents for parenteral anticoagulants.
Diana M. Sobieraj, PharmD, BCPS, earned her doctor of pharmacy degree from the University of Rhode Island and subsequently completed a pharmacy practice residency at Hartford Hospital/The University of Connecticut (UCONN) School of Pharmacy. After her training, Dr. Sobieraj joined the faculty at UCONN School of Pharmacy, where she has worked for the past 8 years. Currently, Dr. Sobieraj is an assistant professor in the Department of Pharmacy Practice in the tenure track. Her scholarly interests focus on comparative effectiveness and health outcomes research of anticoagulants and the treatment and prevention of thrombosis. Dr. Sobieraj has more than 40 publications in the peer-reviewed literature, including journals such as the Annals of Internal Medicine, Journal of the American Geriatrics Society, International Journal of Cardiology, and Thrombosis Research. Dr. Sobieraj is a member of the American College of Clinical Pharmacy, the current Secretary/Treasurer of the American College of Clinical Pharmacy Health Outcomes PRN, and a member of the Community Advisory Panel of the American College of Clinical Pharmacy Practice-Based Research Network.
- Courses must be completed on or before the expiration date noted in the course description above.
- You must score 75% or higher on the final exam and complete the course evaluation to pass this course and have your record transmitted to your NABP e-Profile account.
- Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
- All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.